Eaton Vance Management decreased its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 1.0% in the 4th quarter, Holdings Channel.com reports. The firm owned 93,391 shares of the company’s stock after selling 918 shares during the quarter. Eaton Vance Management’s holdings in Henry Schein were worth $6,244,000 at the end of the most recent reporting period.
A number of other large investors also recently modified their holdings of HSIC. BlackRock Inc. increased its position in Henry Schein by 6.8% in the 4th quarter. BlackRock Inc. now owns 13,083,067 shares of the company’s stock valued at $874,737,000 after acquiring an additional 830,255 shares during the period. Alliancebernstein L.P. increased its position in Henry Schein by 2.2% in the 4th quarter. Alliancebernstein L.P. now owns 2,855,386 shares of the company’s stock valued at $190,911,000 after acquiring an additional 60,216 shares during the period. State of Wisconsin Investment Board increased its position in Henry Schein by 1.0% in the 4th quarter. State of Wisconsin Investment Board now owns 1,689,542 shares of the company’s stock valued at $112,963,000 after acquiring an additional 17,058 shares during the period. Swedbank acquired a new position in Henry Schein in the 4th quarter valued at approximately $104,373,000. Finally, Norges Bank acquired a new position in Henry Schein in the 4th quarter valued at approximately $92,675,000. 94.73% of the stock is owned by institutional investors and hedge funds.
In related news, Director Deborah Derby purchased 760 shares of Henry Schein stock in a transaction on Wednesday, February 24th. The stock was acquired at an average cost of $66.22 per share, for a total transaction of $50,327.20. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.05% of the company’s stock.
NASDAQ:HSIC opened at $69.39 on Monday. The company has a current ratio of 1.49, a quick ratio of 0.92 and a debt-to-equity ratio of 0.14. The stock has a market capitalization of $9.87 billion, a price-to-earnings ratio of 17.09, a PEG ratio of 3.12 and a beta of 0.86. The firm has a fifty day simple moving average of $65.99 and a two-hundred day simple moving average of $65.86. Henry Schein, Inc. has a 12 month low of $49.83 and a 12 month high of $74.89.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, February 16th. The company reported $1.00 EPS for the quarter, topping analysts’ consensus estimates of $0.99 by $0.01. The business had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $2.86 billion. Henry Schein had a net margin of 6.14% and a return on equity of 11.60%. During the same period last year, the company posted $0.97 earnings per share. Equities analysts predict that Henry Schein, Inc. will post 2.93 earnings per share for the current fiscal year.
Henry Schein Company Profile
Henry Schein, Inc engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Featured Story: The Role of a Fiduciary and Individual Investors
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.